Dianne L. Scott, MD

Quotable:
Our faculty and staff go the extra mile to ensure patient comfort and safety and because of this our satisfaction rating is quite high.

Dr. Dianne L. Scott is particularly interested in investigations into the ability of calcium channel blockers to reverse narcotic tolerance within humans. The results of this study could significantly affect management of chronic and acute pain where the use of narcotics is unavoidable. This is of notable importance to her since she specializes in all aspects of anesthetic care.

Her areas of expertise include general anesthesia, regional anesthesia (spinal anesthesia, epidural anesthesia and nerve blocks) and intravenous sedation.

Dr. Scott has 23 years of experience in anesthesiology and chronic pain management. She is a Diplomate of the American Board of Anesthesiology with special certification in pain management. She has extensive experience in nerve blocks such as spinals, epidurals and regional blocks.

Department:
Anesthesiology

Division:
Anesthesiology

Training:
  • MD, University of North Carolina-Chapel Hill School of Medicine, 1978

Residency:
  • Anesthesiology, UNC Hospitals, 1979-1981

Fellowship:
  • Pain Management, UNC Hospitals, 1981-1982

Clinical Interests:
General anesthesiology, chronic pain, ambulatory anesthesia for cosmetic surgery

Research Interests:
Analgesic tolerance or habituation has long been the limiting factor in the use of narcotics as an adjuvant in treatment of chronic pain situations.  Several investigators have studied the causes for tolerance development in the animal.  Only Contreras, et al presented clinically useful information in their study using the mouse model when they proposed that calcium channel blockers may be useful in antagonizing morphine tolerance.   Although analgesic tolerance (loss of pain relieving ability) has been well established in using the animal model, few studies have been done using human subjects.  In our institution, it has been suggested that analgesic tolerance to the narcotic fentanyl can occur in humans after four hours or less of continuous infusion.    The purposes of this prospective crossover study on human volunteers are to document the occurrence of acute tolerance to narcotics in four hours or less during a continuous infusion and to investigate whether Contreras' findings of reversing narcotic tolerance with calcium channel blockers are reproducible in the human.  These results could significantly affect management of chronic and acute pain where the use of narcotics is unavoidable.  Narcotic response will be tested by experimentally induced pain using the submaximal tourniquet test.